New Light-Based device could spot troubled skin flaps after breast surgery
NCT ID NCT07680296
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This pilot study tests a near-infrared (NIR) imaging device that measures oxygen levels in breast skin flaps during and after mastectomy with immediate reconstruction. The goal is to see if the device can reliably detect areas with poor blood flow that might lead to healing problems. Twenty women scheduled for mastectomy will have NIR scans before, during, and after surgery, while receiving standard care. The device is experimental and does not change how surgeons operate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Snapshot NIR V3.0 device
What this could lead to
If successful, this device could help surgeons identify poorly perfused skin flaps early, potentially reducing complications after breast reconstruction.
What could go wrong
This is a small pilot study with only 20 participants, so results may not apply to all patients. The device is not yet approved and does not guide surgical decisions during the trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Long-Term Heart Effects of Anthracycline in Brea NCT07680855
- Trastuzumab + RAD001 for HER2+ Breast Cancer NCT00317720
- AMPLIFI: Web-Based Lifestyle Program for Cancer NCT04000880
- Cognitive Stimulation for Elderly Breast Cancer NCT04261153
- TIBEC Trial: Tislelizumab Combo for Advanced Tum NCT07681297
- Cognitive difficulties after breast cancer: feas NCT04213365
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
U.O. Senologia, Azienda Ospedaliero-Universitaria Pisana (AOUP) Presidio Ospedaliero Santa Chiara
Pisa, 56126, Italy